Crohn's disease: open trials in Norway

11 open trials have a site in Norway. Registry data; only the trial team decides who can take part.

NCT05923073
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Akershus University Hospital, Lorenskog · Oslo University Hospital HF, Oslo · Universitetssykehuset Nord-Norge HF, Tromsoe · St. Olavs hospital HF, Trondheim
Registry updated 2026-11-03
NCT06663332
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Akershus University Hospital, Loerenskog · Oslo Universitetssykehus HF, Oslo · Universitetssykehuset Nord-Norge HF, Tromsoe
Registry updated 2026-11-03
NCT07577843
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Helse Moere Og Romsdal HF, Aalesund · Sykehuset Innlandet HF, Gjoevik · Akershus University Hospital, Loerenskog · Sykehuset Ostfold HF, Moss · Universitetssykehuset Nord-Norge HF, Tromsoe · St. Olavs hospital HF, Trondheim
Registry updated 2026-11-03
NCT06233461
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 2 · Takeda
Vestre Viken HF, Drammen · Sykehuset Innlandet HF, Gjoevik · Akershus University Hospital, Loerenskog · Oslo University Hospital HF, Oslo
Registry updated 2026-11-02
NCT07184931
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Sanofi
Lorenskog · Tromsø
Registry updated 2026-10-21
NCT04844606
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Trial Treatment · Phase 3 · Eli Lilly and Company
Akershus universitetssykehus, Lørenskog · Oslo Universitetssykehus Ullevål, Oslo · Universitetssykehuset Nord-Norge HF, Tromsø · St Olavs Hospital, Trondheim
Registry updated 2026-10-07
NCT05509777
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Trial Treatment · Phase 3 · Eli Lilly and Company
Akershus University Hospital, Lorenskog · Oslo University Hospital HF, Oslo · Universitetssykehuset Nord-Norge HF, Tromsoe · St. Olavs hospital HF, Trondheim
Registry updated 2026-10-07
NCT06548542
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Trial Treatment · Phase 2 · AbbVie
Helse Moere Og Romsdal HF, Aalesund · Akershus University Hospital, Loerenskog · Oslo University Hospital HF, Oslo
Registry updated 2026-09-25
NCT06227910
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Trial Treatment · Phase 3 · Takeda
Helse Bergen HF, Bergen · Vestre Viken HF, Gjettum · Akershus University Hospital, Lorenskog · Oslo University Hospital HF, Oslo
Registry updated 2026-05-27
NCT06764615
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Trial Treatment · Phase 2 · Takeda
Akershus University Hospital, Loerenskog · Oslo University Hospital HF, Oslo
Registry updated 2026-05-22
NCT06468774
Intestinal Ischemia Biomarker in Patients With Chronic Mesenteric Ischemia
Research · Oslo University Hospital
Department of vascular surgery, Oslo University Hospital, Oslo
Registry updated 2025-07-30

All Crohn's disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error